Epidemiology of Genital Herpes Simplex Virus Infections in a Community-Based Sample in France: Results of the HERPIMAX Study. Denis Malvy, MD, PhD; Bruno Halioua, MD; Florian Lançon, MASc; Ali Rezvani, PhD; Sandrine Betrais, PhD; Bruno Chanzy, MD; Michel Daniloski, MD; Khaled Ezzedine, MD; Jean-Elie Malkin, MD; Patrice Morand, MD, PhD; Cecile De Labareyre, MD; Serge Hercberg, MD, PhD; Abdelkader El Hasnaoui, MD, PhD Sex Transm Dis 2005; 32:499–505.
The published version of this article contained two errors for which the authors are responsible. The first relates to the attribution of subjects to the different study populations in the description of the clinical prevalence of genital herpes in the general population and the second to the distribution of study subjects between the study populations in Figure 1. The corrected version of the text and the figure appear below.
Clinical Prevalence of Genital Herpes in the General Population
The replies from the questionnaire provided by 7,821 subjects were used to classify the diagnoses of the participants into either clinically probable or improbable genital herpes, the 994 subjects from population S to whom the questionnaire was sent but who did not provide any data being categorized as improbable genital herpes. The improbable genital herpes group represented 88.2% of population C (n = 6,897), whereas 11.8% (922) were classified as clinically probable genital herpes. The age and gender distribution of these subjects as a function of clinical prevalence is presented in Table 3. The prevalence of clinically probable genital herpes was more frequent in women; there were no overall differences in prevalence according to age.